Home / MEDXF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MEDXF make money? Does MEDXF have pricing power? What's the Earnings Whisper? Will MEDXF profit more as the business scales? What is MEDXF's management track record? Is MEDXF's current price justified?

Medexus Pharmaceuticals Inc.

$3.58 +$1.34 (+60.04%)

OTC · 15 Sep 2026 15:48 UTC

Previous Close

$3.62

Day Range

$3.52$3.6

Year Range

$1.8$3.96

Market Cap

113.5M

AVG Volume

13.92K

Trailing/Forward PE

-46.72/20.37

PEG ratio

-0.21

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

Other OTC

Revenue (USD)

MEDXF Revenue (USD) by year
Period	Revenue (USD)
2026	99.33M
2025	108.33M
2024	113.05M
2023	108.1M
2022	76.52M
2021	96.51M
2020	74.62M
2019	33.86M
2018	9.37M
2017	6.21M

Net Income (USD)

MEDXF Net Income (USD) by year
Period	Net Income (USD)
2026	-2.39M
2025	2.25M
2024	-214K
2023	1.22M
2022	-2.88M
2021	-33.42M
2020	-4.4M
2019	-5.05M
2018	-2.67M
2017	-1.35M

Operating Income (USD)

MEDXF Operating Income (USD) by year
Period	Operating Income (USD)
2026	5.83M
2025	8.22M
2024	10.79M
2023	8.49M
2022	-15M
2021	421.84K
2020	-927.37K
2019	-4.61M
2018	-2.53M
2017	-789.55K

EBITDA (USD)

MEDXF EBITDA (USD) by year
Period	EBITDA (USD)
2026	12.66M
2025	16.81M
2024	19.96M
2023	15.51M
2022	13.88M
2021	8.75M
2020	5.17M
2019	1.8M
2018	-2.61M
2017	-1.02M

Cash Flows (USD)

MEDXF Cash Flows (USD) by year
Period	Cash Flows (USD)
2026	3.72M
2025	21.31M
2024	18.45M
2023	-1.81M
2022	-8.89M
2021	-5.93M
2020	-2.46M
2019	-2.8M
2018	-3.5M
2017	-1.25M

EPS (USD)

MEDXF EPS (USD) by year
Period	EPS (USD)
2026	-0.07
2025	0.09
2024	-0
2023	0.06
2022	-0.15
2021	-1.88
2020	-0.31
2019	-0.71
2018	-0.48
2017	-0.27

Expenses (USD)

MEDXF Expenses (USD) by year
Period	Expenses (USD)
2026	61.79M
2025	47.14M
2024	43.52M
2023	50.81M
2022	57.51M
2021	59.81M
2020	43.7M
2019	23.75M
2018	6.61M
2017	6.28M

Cash & Debt (USD)

MEDXF Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2026	6.52M
2025	23.97M
2024	5.25M
2023	13.07M
2022	10.02M
2021	18.7M
2020	5.23M
2019	21.87M
2018	2.79M
2017	2.43M

Debt ratios

MEDXF Debt ratios by year
Period	Debt ratios
2026	0.24
2025	0.2
2024	0.77
2023	1.32
2022	1.52
2021	1.99
2020	10.02
2019	-5.11

Margins

MEDXF Margins by year
Period	Margins
2026	54.78%
2025	52.23%
2024	52.64%
2023	55.54%
2022	49.56%
2021	42.22%
2020	39.28%
2019	65.4%
2018	44.68%
2017	51.72%

Return on Capital

MEDXF Return on Capital by year
Period	Return on Capital
2026	-4.89%
2025	4.31%
2024	-0.71%
2023	5.44%
2022	-16.18%
2021	-185.49%
2020	-18.1%
2019	-18.11%
2018	-113.55%
2017	-138.52%

Shares Outstanding

MEDXF Shares Outstanding by year
Period	Shares Outstanding
2026	32.03M
2025	27.65M
2024	24.46M
2023	22.13M
2022	19.95M
2021	17.18M
2020	14.27M
2019	11.6M
2018	5.76M
2017	5.05M

Book Value Per Share (USD)

MEDXF Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2026	1.53
2025	1.89
2024	1.24
2023	1.01
2022	0.89
2021	1.05
2020	1.7
2019	2.4
2018	0.41
2017	0.19

Total Assets (USD)

MEDXF Total Assets (USD) by year
Period	Total Assets (USD)
2026	147.28M
2025	171.84M
2024	155.73M
2023	161.33M
2022	139.22M
2021	148.51M
2020	122.81M
2019	85.01M
2018	7.17M
2017	5.79M

PE Ratio

MEDXF PE Ratio by year
Period	PE Ratio
Mar 26	192.37
Mar 26	193.22
Mar 26	193.22
Mar 26	194.07
Feb 26	178.81
Feb 26	178.81
Feb 26	177.96
Feb 26	175.42
Jan 26	174.57
Jan 26	175.42
Jan 26	168.64
Jan 26	177.12
Jan 26	189.83
Dec 25	80.85
Dec 25	77.24
Dec 25	74.84
Dec 25	76.44
Nov 25	80.05
Nov 25	76.04
Nov 25	74.44
Nov 25	75.64
Oct 25	78.44
Oct 25	82.05
Oct 25	78.44
Oct 25	78.84
Oct 25	82.45
Sep 25	24.49
Sep 25	27.19
Sep 25	27.56
Sep 25	27.07
Aug 25	27.07
Aug 25	25.6
Aug 25	26.21
Aug 25	23.5
Aug 25	24
Jul 25	25.47
Jul 25	25.23
Jul 25	26.21
Jul 25	27.93
Jun 25	15.93
Jun 25	16.21
Jun 25	14.89
Jun 25	14.82
May 25	14.62
May 25	13.92
May 25	13.3
May 25	14.55
May 25	13.99
Apr 25	13.37
Apr 25	12.33
Apr 25	10.67
Apr 25	10.53
Mar 25	17.69
Mar 25	20.15
Mar 25	18.87
Mar 25	19.72
Feb 25	20.79
Feb 25	21.21
Feb 25	23.02
Feb 25	24.2
Jan 25	28.35
Jan 25	36.67
Jan 25	31.98
Jan 25	29.21
Jan 25	25.37
Dec 24	50.85
Dec 24	42.56
Dec 24	45.48
Dec 24	45.92
Nov 24	42.79
Nov 24	38.08
Nov 24	34.27
Nov 24	34.27
Nov 24	38.08
Oct 24	41.44
Oct 24	42.11
Oct 24	43.46
Oct 24	43.91
Jun 24	5.47
Jun 24	4.98
Jun 24	4.69
Jun 24	5.39
May 24	4.81
May 24	4.85
May 24	4.89
May 24	4.89
May 24	5.35
Apr 24	5.72
Apr 24	5.02
Apr 24	4.69
Apr 24	4.85
Mar 24	5.08
Mar 24	4.79
Mar 24	4.87
Mar 24	5.25
Mar 24	5.58
Feb 24	5.12
Feb 24	5.41
Feb 24	5.62
Feb 24	7.7

Free Cash Flow Yield

MEDXF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	3.21%
Sep 26	3.18%
Sep 26	3.15%
Aug 26	3.2%
Aug 26	3.11%
Aug 26	3.03%
Aug 26	3.21%
Jul 26	3.26%
Jul 26	3.27%
Jul 26	3.16%
Jul 26	3.17%
Jul 26	3.21%
Jun 26	18.31%
Jun 26	18.37%
Jun 26	18.12%
Jun 26	19.1%
May 26	18.97%
May 26	18.25%
May 26	17.94%
May 26	18.31%
May 26	18.06%
Apr 26	18.31%
Apr 26	18.12%
Apr 26	18.57%
Apr 26	21.17%
Mar 26	21.77%
Mar 26	21.67%
Mar 26	21.67%
Mar 26	21.58%
Feb 26	23.42%
Feb 26	23.42%
Feb 26	23.53%
Feb 26	23.87%
Jan 26	23.98%
Jan 26	23.87%
Jan 26	24.83%
Jan 26	23.64%
Jan 26	22.06%
Dec 25	26%
Dec 25	27.21%
Dec 25	28.08%
Dec 25	27.5%
Nov 25	26.26%
Nov 25	27.64%
Nov 25	28.23%
Nov 25	27.79%
Oct 25	26.79%
Oct 25	25.62%
Oct 25	26.79%
Oct 25	26.66%
Oct 25	25.49%
Sep 25	38.73%
Sep 25	34.87%
Sep 25	34.4%
Sep 25	35.03%
Aug 25	35.03%
Aug 25	37.05%
Aug 25	36.18%
Aug 25	40.35%
Aug 25	39.52%
Jul 25	37.23%
Jul 25	37.59%
Jul 25	36.18%
Jul 25	33.95%
Jun 25	36.08%
Jun 25	35.46%
Jun 25	38.59%
Jun 25	38.77%
May 25	39.32%
May 25	41.28%
May 25	43.22%
May 25	39.51%
May 25	41.08%
Apr 25	42.99%
Apr 25	46.61%
Apr 25	53.88%
Apr 25	54.59%
Mar 25	47.79%
Mar 25	41.97%
Mar 25	44.82%
Mar 25	42.88%
Feb 25	40.68%
Feb 25	39.86%
Feb 25	36.72%
Feb 25	34.95%
Jan 25	29.82%
Jan 25	23.06%
Jan 25	26.44%
Jan 25	28.95%
Jan 25	33.33%
Dec 24	40.38%
Dec 24	48.24%
Dec 24	45.15%
Dec 24	44.71%
Nov 24	47.99%
Nov 24	53.92%
Nov 24	59.91%
Nov 24	59.91%
Nov 24	53.92%
Oct 24	49.55%

Price to Sales

MEDXF Price to Sales by year
Period	Price to Sales
Sep 26	1.17
Sep 26	1.18
Sep 26	1.19
Aug 26	1.17
Aug 26	1.21
Aug 26	1.23
Aug 26	1.17
Jul 26	1.15
Jul 26	1.14
Jul 26	1.19
Jul 26	1.18
Jul 26	1.17
Jun 26	0.94
Jun 26	0.94
Jun 26	0.95
Jun 26	0.9
May 26	0.91
May 26	0.95
May 26	0.96
May 26	0.94
May 26	0.96
Apr 26	0.94
Apr 26	0.95
Apr 26	0.93
Apr 26	0.82
Mar 26	0.7
Mar 26	0.71
Mar 26	0.71
Mar 26	0.71
Feb 26	0.65
Feb 26	0.65
Feb 26	0.65
Feb 26	0.64
Jan 26	0.64
Jan 26	0.64
Jan 26	0.62
Jan 26	0.65
Jan 26	0.69
Dec 25	0.62
Dec 25	0.59
Dec 25	0.57
Dec 25	0.58
Nov 25	0.61
Nov 25	0.58
Nov 25	0.57
Nov 25	0.58
Oct 25	0.6
Oct 25	0.63
Oct 25	0.6
Oct 25	0.6
Oct 25	0.63
Sep 25	0.51
Sep 25	0.56
Sep 25	0.57
Sep 25	0.56
Aug 25	0.56
Aug 25	0.53
Aug 25	0.54
Aug 25	0.49
Aug 25	0.5
Jul 25	0.53
Jul 25	0.52
Jul 25	0.54
Jul 25	0.58
Jun 25	0.52
Jun 25	0.53
Jun 25	0.48
Jun 25	0.48
May 25	0.48
May 25	0.45
May 25	0.43
May 25	0.47
May 25	0.46
Apr 25	0.43
Apr 25	0.4
Apr 25	0.35
Apr 25	0.34
Mar 25	0.39
Mar 25	0.44
Mar 25	0.41
Mar 25	0.43
Feb 25	0.46
Feb 25	0.46
Feb 25	0.5
Feb 25	0.53
Jan 25	0.62
Jan 25	0.8
Jan 25	0.7
Jan 25	0.64
Jan 25	0.56
Dec 24	0.51
Dec 24	0.43
Dec 24	0.46
Dec 24	0.46
Nov 24	0.43
Nov 24	0.38
Nov 24	0.34
Nov 24	0.34
Nov 24	0.38
Oct 24	0.42

EV/EBITDA

MEDXF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	10.4
Sep 26	10.48
Sep 26	10.58
Aug 26	10.43
Aug 26	10.7
Aug 26	10.93
Aug 26	10.4
Jul 26	10.25
Jul 26	10.22
Jul 26	10.55
Jul 26	10.53
Jul 26	10.4
Jun 26	6.59
Jun 26	6.57
Jun 26	6.65
Jun 26	6.34
May 26	6.38
May 26	6.61
May 26	6.71
May 26	6.59
May 26	6.67
Apr 26	6.59
Apr 26	6.65
Apr 26	6.51
Apr 26	5.79
Mar 26	5.22
Mar 26	5.24
Mar 26	5.24
Mar 26	5.26
Feb 26	4.91
Feb 26	4.91
Feb 26	4.89
Feb 26	4.83
Jan 26	4.81
Jan 26	4.83
Jan 26	4.67
Jan 26	4.87
Jan 26	5.16
Dec 25	4.88
Dec 25	4.7
Dec 25	4.58
Dec 25	4.66
Nov 25	4.84
Nov 25	4.64
Nov 25	4.56
Nov 25	4.62
Oct 25	4.76
Oct 25	4.94
Oct 25	4.76
Oct 25	4.78
Oct 25	4.96
Sep 25	4.06
Sep 25	4.42
Sep 25	4.47
Sep 25	4.4
Aug 25	4.4
Aug 25	4.21
Aug 25	4.29
Aug 25	3.93
Aug 25	3.99
Jul 25	4.19
Jul 25	4.16
Jul 25	4.29
Jul 25	4.52
Jun 25	4.77
Jun 25	4.83
Jun 25	4.57
Jun 25	4.56
May 25	4.52
May 25	4.39
May 25	4.27
May 25	4.51
May 25	4.4
Apr 25	4.28
Apr 25	4.08
Apr 25	3.76
Apr 25	3.73
Mar 25	4.47
Mar 25	4.79
Mar 25	4.62
Mar 25	4.74
Feb 25	4.88
Feb 25	4.94
Feb 25	5.18
Feb 25	5.34
Jan 25	5.89
Jan 25	7
Jan 25	6.38
Jan 25	6.01
Jan 25	5.49
Dec 24	5.02
Dec 24	4.53
Dec 24	4.7
Dec 24	4.73
Nov 24	4.55
Nov 24	4.27
Nov 24	4.05
Nov 24	4.05
Nov 24	4.27
Oct 24	4.47

Price/Operating Cashflow

MEDXF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	6.14
Sep 26	6.19
Sep 26	6.26
Aug 26	6.16
Aug 26	6.35
Aug 26	6.5
Aug 26	6.14
Jul 26	6.04
Jul 26	6.02
Jul 26	6.24
Jul 26	6.23
Jul 26	6.14
Jun 26	5.4
Jun 26	5.38
Jun 26	5.45
Jun 26	5.17
May 26	5.21
May 26	5.42
May 26	5.51
May 26	5.4
May 26	5.47
Apr 26	5.4
Apr 26	5.45
Apr 26	5.32
Apr 26	4.67
Mar 26	4.51
Mar 26	4.53
Mar 26	4.53
Mar 26	4.55
Feb 26	4.19
Feb 26	4.19
Feb 26	4.17
Feb 26	4.12
Jan 26	4.1
Jan 26	4.12
Jan 26	3.96
Jan 26	4.15
Jan 26	4.45
Dec 25	3.3
Dec 25	3.15
Dec 25	3.05
Dec 25	3.12
Nov 25	3.27
Nov 25	3.1
Nov 25	3.04
Nov 25	3.09
Oct 25	3.2
Oct 25	3.35
Oct 25	3.2
Oct 25	3.22
Oct 25	3.36
Sep 25	2.29
Sep 25	2.54
Sep 25	2.58
Sep 25	2.53
Aug 25	2.53
Aug 25	2.39
Aug 25	2.45
Aug 25	2.2
Aug 25	2.24
Jul 25	2.38
Jul 25	2.36
Jul 25	2.45
Jul 25	2.61
Jun 25	2.43
Jun 25	2.47
Jun 25	2.27
Jun 25	2.26
May 25	2.23
May 25	2.12
May 25	2.03
May 25	2.22
May 25	2.13
Apr 25	2.04
Apr 25	1.88
Apr 25	1.63
Apr 25	1.61
Mar 25	1.83
Mar 25	2.08
Mar 25	1.95
Mar 25	2.04
Feb 25	2.15
Feb 25	2.19
Feb 25	2.38
Feb 25	2.5
Jan 25	2.93
Jan 25	3.79
Jan 25	3.31
Jan 25	3.02
Jan 25	2.62
Dec 24	2.45
Dec 24	2.05
Dec 24	2.19
Dec 24	2.21
Nov 24	2.06
Nov 24	1.83
Nov 24	1.65
Nov 24	1.65
Nov 24	1.83
Oct 24	1.99

Price to Book

MEDXF Price to Book by year
Period	Price to Book
Sep 26	2.37
Sep 26	2.39
Sep 26	2.41
Aug 26	2.37
Aug 26	2.44
Aug 26	2.5
Aug 26	2.37
Jul 26	2.33
Jul 26	2.32
Jul 26	2.41
Jul 26	2.4
Jul 26	2.37
Jun 26	1.8
Jun 26	1.79
Jun 26	1.81
Jun 26	1.72
May 26	1.73
May 26	1.8
May 26	1.83
May 26	1.8
May 26	1.82
Apr 26	1.8
Apr 26	1.81
Apr 26	1.77
Apr 26	1.55
Mar 26	1.4
Mar 26	1.4
Mar 26	1.4
Mar 26	1.41
Feb 26	1.3
Feb 26	1.3
Feb 26	1.29
Feb 26	1.28
Jan 26	1.27
Jan 26	1.28
Jan 26	1.23
Jan 26	1.29
Jan 26	1.38
Dec 25	1.23
Dec 25	1.18
Dec 25	1.14
Dec 25	1.16
Nov 25	1.22
Nov 25	1.16
Nov 25	1.13
Nov 25	1.15
Oct 25	1.19
Oct 25	1.25
Oct 25	1.19
Oct 25	1.2
Oct 25	1.25
Sep 25	1.06
Sep 25	1.17
Sep 25	1.19
Sep 25	1.17
Aug 25	1.17
Aug 25	1.1
Aug 25	1.13
Aug 25	1.01
Aug 25	1.03
Jul 25	1.1
Jul 25	1.09
Jul 25	1.13
Jul 25	1.2
Jun 25	1.71
Jun 25	1.74
Jun 25	1.6
Jun 25	1.6
May 25	1.57
May 25	1.5
May 25	1.43
May 25	1.57
May 25	1.51
Apr 25	1.44
Apr 25	1.33
Apr 25	1.15
Apr 25	1.13
Mar 25	1.24
Mar 25	1.41
Mar 25	1.32
Mar 25	1.38
Feb 25	1.46
Feb 25	1.49
Feb 25	1.61
Feb 25	1.7
Jan 25	1.99
Jan 25	2.57
Jan 25	2.24
Jan 25	2.05
Jan 25	1.78
Dec 24	1.7
Dec 24	1.43
Dec 24	1.52
Dec 24	1.54
Nov 24	1.43
Nov 24	1.28
Nov 24	1.15
Nov 24	1.15
Nov 24	1.28
Oct 24	1.39

No video analysis for this stock yet. Request one from our team.

News: MEDXF

newsfilecorp.com · 10 Aug 2026

Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date

Fiscal Q1 2027 includes product-level net revenue from GRAFAPEX™ (treosulfan) for Injection of $4.9 million relative to $3.2 million of GRAFAPEX personnel and infrastructure investments Commercial traction observed to date reinforces Medexus confidence in the growth trajectory of GRAFAPEX Management to host conference call at 8:00 AM Eastern time on Tuesday, August 11, 2026 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 10, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's first fiscal quarter ended June 30, 2026 (the Company's fiscal Q1 2027). All dollar amounts in this news release are in US dollars unless specified otherwise.

newsfilecorp.com · 30 Jul 2026

Medexus Schedules First Fiscal Quarter 2027 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Tuesday, August 11, 2026 to discuss Medexus's results for its first fiscal quarter ended June 30, 2026. Medexus expects to file its financial statements and MD&A after markets close on August 10, 2026.

newsfilecorp.com · 25 Jun 2026

Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

Management to host conference call at 8:00 AM Eastern time on Friday, June 26, 2026 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's fourth fiscal quarter and fiscal year ended March 31, 2026 (the company's fiscal Q4 2026 and fiscal year 2026). All dollar amounts in this news release are in US dollars unless specified otherwise.

newsfilecorp.com · 16 Jun 2026

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026.